Al's Comment:

 The NCCN guidelines are important because many insurance plans base their payment decisions upon these guidelines! The new version lists  "alternating electric field therapy" (Novocure TTF100-A is the only FDA approved alternating electric field therapy device) as an option for both local or multiple/diffuse recurrences of GBMs.

 


Posted on: 01/09/2013

To view the guidelines, go to:

www.nccn.org/professionals/physician_gls/pdf/cns.pdf

A free registration is required

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click HERE to read it!